Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Jeil Pharmaceutical Co. Ltd.
DescriptionPoly(ADP-ribose) polymerase-1 (PARP-1) inhibitor
Molecular Target Poly(ADP-ribose) polymerase-1 (PARP-1)
Mechanism of ActionPoly(ADP-ribose) polymerase-1 (PARP-1) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationStroke
Indication DetailsTreat stroke
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today